KLHL22 activators represent a class of chemical compounds or molecules designed to modulate the activity or expression of the KLHL22 gene. KLHL22, short for Kelch-like protein 22, is a human gene that encodes a protein belonging to the Kelch-like (KLHL) family. Members of the KLHL family are known to play essential roles in various cellular processes, including protein ubiquitination and degradation. KLHL22 specifically acts as a substrate adaptor for the Cullin3 (CUL3)-based E3 ubiquitin ligase complex. This complex is involved in the ubiquitination and subsequent degradation of specific target proteins within the cell.
KLHL22 activators have garnered interest in the field of molecular biology and cellular physiology due to their potential to modulate the ubiquitin-proteasome system. By targeting KLHL22, researchers can explore its role in the regulation of protein turnover and degradation. This can lead to a better understanding of how the ubiquitin-proteasome system influences various cellular processes, including cell cycle control, signal transduction, and protein quality control. Studying KLHL22 activators can provide valuable insights into the intricate mechanisms governing protein homeostasis within cells, which is critical for maintaining cellular function and integrity. Moreover, KLHL22 activators have the potential to shed light on the specific substrates targeted by the CUL3-KLHL22 ubiquitin ligase complex, uncovering novel regulatory pathways. Understanding the molecular mechanisms underlying protein degradation mediated by KLHL22 can have implications for a wide range of biological processes and diseases, including cancer, neurodegenerative disorders, and autoimmune conditions, where dysregulation of the ubiquitin-proteasome system has been implicated.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can regulate gene expression through nuclear receptors, potentially affecting KLHL22 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor may lead to demethylation of the KLHL22 gene promoter, potentially upregulating its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it may increase histone acetylation and potentially upregulate KLHL22 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can increase cAMP levels, potentially activating transcription factors that regulate KLHL22. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
This HDAC inhibitor can cause chromatin remodeling, potentially leading to increased expression of KLHL22. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane can induce the expression of antioxidant response elements and may affect gene expression, influencing KLHL22. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known to have epigenetic modulatory effects, which could potentially upregulate KLHL22 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can modulate signaling pathways and has potential epigenetic regulatory effects, which might influence KLHL22 expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
This glucocorticoid can regulate gene expression through its receptor, potentially affecting KLHL22 levels. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Metformin activates AMPK, which can lead to transcriptional changes in metabolic genes, possibly including KLHL22. | ||||||